Technical Analysis for ALDX - Aldeyra Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 7.12 -2.47% -0.18
ALDX closed down 2.47 percent on Monday, May 20, 2019, on 21 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALDX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -2.47%
Lower Bollinger Band Walk Weakness -2.47%

Older signals for ALDX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aldeyra Therapeutics, Inc. (Aldeyra) is a biotechnology company. The Company is focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The Company is developing NS2. NS2 is a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of diseases, which include Sjogren-Larsson Syndrome (SLS), discoid lupus, acute anterior uveitis and ocular rosacea with meibomian gland dysfunction. Aldeyra is also developing aldehyde traps distinct from NS2. As of April 7, 2014, it had evaluated NS2 in a Phase I clinical trial in 48 volunteers.
Medicine Biotechnology Medical Specialties Diseases Organ Systems Autoimmune Diseases Rare Diseases Uveitis Inflammatory Syndromes
Is ALDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.7
52 Week Low 6.75
Average Volume 755,444
200-Day Moving Average 8.9244
50-Day Moving Average 8.211
20-Day Moving Average 7.8825
10-Day Moving Average 7.592
Average True Range 0.3682
ADX 15.64
+DI 15.3257
-DI 25.8273
Chandelier Exit (Long, 3 ATRs ) 7.365400000000001
Chandelier Exit (Short, 3 ATRs ) 8.2046
Upper Bollinger Band 8.6423
Lower Bollinger Band 7.1227
Percent B (%b) 0.0
BandWidth 19.278148
MACD Line -0.2599
MACD Signal Line -0.1793
MACD Histogram -0.0806
Fundamentals Value
Market Cap 44.47 Million
Num Shares 6.25 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -4.84
Price-to-Sales 0.00
Price-to-Book 4.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.33
Resistance 3 (R3) 7.35 7.29 7.30
Resistance 2 (R2) 7.29 7.24 7.29 7.28
Resistance 1 (R1) 7.21 7.21 7.18 7.19 7.27
Pivot Point 7.15 7.15 7.14 7.15 7.15
Support 1 (S1) 7.07 7.10 7.04 7.05 6.97
Support 2 (S2) 7.01 7.07 7.01 6.96
Support 3 (S3) 6.93 7.01 6.95
Support 4 (S4) 6.91